Human Metabolomics
Metabolites can serve as a metabolic disease biomarker. In the study of biochemical reaction and signaling networks detection of such biomarkers plays a significant role. The multicomponent analysis of biological fluids, tissue and cell extracts using NMR spectroscopy and/or mass spectrometry (MS) Metabolic profiling, studies mainly involve metabolomic and metabonomic. In biological systems the measurement of the complement of low-molecular-weight metabolites and their intermediates that reflects the dynamic response to genetic modification and physiological, pathophysiological and/or developmental stimuli is known as Metabolic profiling (metabolomics/metabonomics).The current developments in metabolomics and metabolic profiling technologies have led to the discovery of several new metabolic biomarkers. complete and comprehensive curated collection of human metabolite and human metabolism data in the world is The Human Metabolome Database (HMDB).It contains records thousands of books, journal articles and electronic databases for more than 2180 endogenous metabolites. Metabolomic analyses like mass spectra (MS) and Nuclear Magnetic resonance (NMR) performed on urine, blood and cerebrospinal fluid samples also contains by HMDB In addition to its comprehensive literature-derived data. In the field of biochemists, clinical chemists, physicians, medical geneticists, nutritionists and members of the metabolomics community the HMDB is designed to address.
Related Conference of Human Metabolomics
Human Metabolomics Conference Speakers
Recommended Sessions
- Analytical Platforms in Metabolomics
- Case Reports
- Clinical Metabolomics & Lipidomics
- Frontiers of Metabolomics Research
- Human Metabolomics
- Mass Spectrometry based Metabolomics
- Metabolic Modelling
- Metabolic Syndrome
- Metabolomic Analysis
- Metabolomic Devices
- Metabolomic profiling
- Metabolomics and Cancer Research
- Metabolomics in Precision Medicine
- Plant & Environmental Metabolomics
- Protein Expression and Analysis
- Proteomics and its Medicinal Research
- Proteomics for Bioinformatics
- Proteomics from Discovery to Function
- Single Cell Metabolomics
- Urine Metabolomics
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
